rs142888296
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PP3_Moderate
The ENST00000274576.9(GLRA1):c.199G>A(p.Val67Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000334 in 1,612,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000274576.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLRA1 | NM_000171.4 | c.199G>A | p.Val67Met | missense_variant | 3/9 | ENST00000274576.9 | NP_000162.2 | |
GLRA1 | NM_001146040.2 | c.199G>A | p.Val67Met | missense_variant | 3/9 | NP_001139512.1 | ||
GLRA1 | XM_047417105.1 | c.247G>A | p.Val83Met | missense_variant | 3/9 | XP_047273061.1 | ||
GLRA1 | NM_001292000.2 | c.-51G>A | 5_prime_UTR_variant | 2/8 | NP_001278929.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLRA1 | ENST00000274576.9 | c.199G>A | p.Val67Met | missense_variant | 3/9 | 1 | NM_000171.4 | ENSP00000274576 | P4 | |
GLRA1 | ENST00000455880.2 | c.199G>A | p.Val67Met | missense_variant | 3/9 | 1 | ENSP00000411593 | A1 | ||
GLRA1 | ENST00000471351.2 | n.482G>A | non_coding_transcript_exon_variant | 3/8 | 1 | |||||
GLRA1 | ENST00000462581.6 | c.71G>A | p.Arg24His | missense_variant, NMD_transcript_variant | 2/8 | 1 | ENSP00000430595 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000163 AC: 41AN: 251238Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135766
GnomAD4 exome AF: 0.000349 AC: 510AN: 1460612Hom.: 0 Cov.: 29 AF XY: 0.000316 AC XY: 230AN XY: 726742
GnomAD4 genome AF: 0.000184 AC: 28AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74494
ClinVar
Submissions by phenotype
Hereditary hyperekplexia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 67 of the GLRA1 protein (p.Val67Met). This variant is present in population databases (rs142888296, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of autosomal recessive hyperekplexia (PMID: 30182260; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 575744). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GLRA1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
GLRA1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 09, 2023 | The GLRA1 c.199G>A variant is predicted to result in the amino acid substitution p.Val67Met. This variant was reported in the compound heterozygous state in an individual with hyperekplexia. The father who carried this variant was unaffected and the mother carrying the second GLRA1 variant (loss of function) was affected by hyperekplexia with a less severe phenotype, suggesting that p.Val67Met may act as a hypomorphic allele only enhancing the phenotype (Milenkovic et al. 2018. PubMed ID: 30182260). This variant is reported in 0.029% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-151266335-C-T). Although we suspect this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 07, 2024 | Reported in an individual with hyperekplexia who inherited the variant from their unaffected father and harbored an additional GLRA1 variant in trans; the additional variant was inherited from a similarly affected mother (PMID: 30182260); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30182260) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at